Thyroid Cancer: Related News

On Our Blog

Peter Scardino, Chair of MSK’s Department of Surgery and a specialist in the treatment of prostate cancers.
Predicting the Future of Cancer Surgery

Peter Scardino, Chair of MSK’s Department of Surgery, gives his views on what lies ahead for the surgical treatment of cancer.

February 24, 2015
Study Reveals Genetic Causes for Thyroid Cancer Increase after Chernobyl

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.

November 13, 2013
Pictured: James Fagin
The Society of MSKCC’s Annual Appeal Raises Funds for Thyroid Cancer Research

This year The Society of MSKCC’s Annual Appeal aims to raise funds to support thyroid cancer research.

September 27, 2013
Pictured: James Fagin
Drug Reverses Radioiodine Resistance in Some People with Advanced Thyroid Cancer

Researchers have found that the investigational drug selumetinib shuts down the signaling of genetic mutations that prevent some patients’ thyroid cancer tumors from absorbing radioiodine, the most effective treatment for the disease.

February 14, 2013
Pictured: James Huang
Meet Thoracic Surgeon James Huang

Dr. Huang discusses how minimally invasive, video-assisted, and robotic surgical techniques improve the treatment of patients with lung, esophageal, and thyroid cancers.

October 31, 2012
Pictured: Mary McCabe
Cancer Survivorship: An Interview with Mary McCabe

In 2003, Mary McCabe was recruited to lead Memorial Sloan Kettering Cancer Center’s Cancer Survivorship Initiative and since that time has worked to develop a comprehensive program for cancer survivors, which includes follow-up care, research, and education and training.

July 1, 2011
Treating Rare Cancers

Memorial Sloan Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.

April 1, 2011
New Technology Will Improve Molecular Testing of Tumors for Patients

Memorial Sloan Kettering has made an important step forward in efficiently diagnosing gene mutations in patients’ cancers on an individual basis.

June 1, 2010
Genetic Information Becomes a Vital Part of Clinical Practice

At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.

October 1, 2008

Related Media Coverage

Why You Should Stop Calling Thyroid Cancer 'Good Cancer'

Medical oncologist Alan Ho discusses thyroid cancer in The Huffington Post.

February 6, 2015
Study Points to Overdiagnosis of Thyroid Cancer

Endocrinologist R. Michael Tuttle and Surgeon Ashok Shaha discuss thyroid cancer in The New York Times.

November 6, 2014
A Disease by Any Other Name: The Cancer Conundrum

Head and neck cancer surgeon Bhuvanesh Singh commented on a paper that found that the number of cases of thyroid cancer in the United States tripled from 1973 to 2009, largely due to more aggressive screening techniques and improved imaging.

August 27, 2013
MEK: A Single Drug Target Shows Promise in Multiple Cancers

Endocrinologist James Fagin spoke about a study he led that found that an investigational drug may help some patients with thyroid cancer who are unable to absorb radioactive iodine, the most effective therapy for the disease.

April 5, 2013